NEWS

We have chosen the most important industry news.

Quick Filters

Results

ALL News Results

Medicare and Alzheimer's Drugs: Pressure To Relax Coverage Restrictions Rising With Donanemab Data

May 07, 2023

Coverage and Access

Alzheimer's drug studied at Butler Hospital shows promise

May 04, 2023

Clinical Trials

US health officials aim to 'transform' Alzheimer's disease research with $300 million data platform

April 05, 2023

Clinical Practice

U.S. Sets Up $300 Million Database for Alzheimer's Research

April 05, 2023

Clinical Practice

Emerging Therapies for Early Alzheimer's Disease

April 03, 2023

FDA Approvals

Decision Date on Leqembi Traditional Approval Set for July

March 10, 2023

FDA Approvals

Experts Reframe 'Clinical Meaningfulness' in Alzheimer's

February 07, 2023

Clinical Trials

Alzheimer’s Association Welcomes U.S. FDA Approval of Lecanemab

January 23, 2023

FDA Approvals

CMS Statement on FDA Accelerated Approval of Lecanemab

January 23, 2023

FDA Approvals

FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment

January 23, 2023

FDA Approvals

Leqembi Label Recommends Alzheimer's Patient Registry: A Nod To Medicare Evidence Demands?

January 19, 2023

FDA Approvals

FDA Approves New Antibody to Slow Alzheimer's Disease, Even as Safety Concerns Linger

January 06, 2023

FDA Approvals

Alzheimer's Network for Treatment and Diagnostics Created to Collect Real-World Data

December 06, 2022

Clinical Practice

Alzheimer's Association Announces National Data Registry for Quick, Transparent Data Sharing

November 16, 2022

Clinical Practice

A New Alzheimer's Drug Gave Patients Hope. Millions Can't Get It

November 01, 2022

Coverage and Access

Lecanemab Confirmatory Phase 3 Clarity Ad Study Shows Significant Reduction of Clinical Decline

September 28, 2022

Clinical Trials

Bringing Aduhelm - and Antibodies to Come - Into Practice

August 30, 2022

Clinical Practice

The Alzheimer’s Treatments, Diagnostics That Could Be Available Soon

August 10, 2022

Clinical Trials

Alzheimer's Association Launches ALZ-NET Registry for Study of New Treatments for Alzheimer's Disease in Real-World Setting

August 02, 2022

Clinical Practice

Alzheimer’s Association Launches ALZ-NET: A Long-Term Data Collection and Sharing Network for New Treatments

August 01, 2022

Coverage and Access

The Fight Against Alzheimer’s: Where Are We Now?

July 31, 2022

Coverage and Access

The Changing Role of the Caregiver

July 19, 2022

Clinical Practice

What It's Like Living with Alzheimer's

July 01, 2022

Coverage and Access

Novel Alzheimer's Drug Stirs Debate (Again)

April 21, 2022

Coverage and Access

Medicare Coverage of Aduhelm Will Be Limited to Patients in Trials

April 11, 2022

Coverage and Access

Aduhelm Lowers Tau; Registry to Track Real-World Performance

November 19, 2021

Clinical Trials

National Alzheimer's Drug Registry Will Track Real-World Results

November 12, 2021

Clinical Practice

National Alzheimer Disease Registry Announced to Collect Clinical Practice Data

November 12, 2021

Clinical Practice

Aduhelm May Not Be Perfect, But It May Be a Start - If Patients Can Access It

November 11, 2021

Coverage and Access

Alzheimer's Association and Partners Announces National Registry

November 11, 2021

Clinical Practice

Working Towards a World Without Alzheimer's and All Other Dementia

November 01, 2021

Clinical Practice

Alzheimer’s Association Welcomes CMS Announcement of National Coverage Determination Analysis on Treatment for Alzheimer’s Disease

July 12, 2021

Coverage and Access

Alzheimer’s Association Welcomes FDA Approval of Aducanumab

June 07, 2021

Coverage and Access

Find medical professionals in your area who are participating in ALZ-NET.

Find a Site